Trial · NCT01976416
Adverse events32
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 32
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Vaso-Occlusive Crisis | Blood and lymphatic system disorders | Hydroxyurea | 38 | 104 | 58 |
| other | Vaso-Occlusive Crisis | Blood and lymphatic system disorders | Placebo | 59 | 103 | 106 |
| other | Pneumonia | Respiratory, thoracic and mediastinal disorders | Hydroxyurea | 21 | 104 | 24 |
| other | Pneumonia | Respiratory, thoracic and mediastinal disorders | Placebo | 24 | 103 | 32 |
| other | Clinical Sepsis | Infections and infestations | Hydroxyurea | 6 | 104 | 8 |
| other | Clinical Sepsis | Infections and infestations | Placebo | 13 | 103 | 16 |
| other | Upper Respiratory Tract Infection | Respiratory, thoracic and mediastinal disorders | Hydroxyurea | 54 | 104 | 107 |
| other | Upper Respiratory Tract Infection | Respiratory, thoracic and mediastinal disorders | Placebo | 62 | 103 | 108 |
| other | Gastrointestinal-related | Gastrointestinal disorders | Hydroxyurea | 13 | 104 | 15 |
| other | Gastrointestinal-related | Gastrointestinal disorders | Placebo | 12 | 103 | 15 |
| other | Malaria | Blood and lymphatic system disorders | Hydroxyurea | 3 | 104 | 5 |
| other | Malaria | Blood and lymphatic system disorders | Placebo | 7 | 103 | 7 |
| other | Other infections | Infections and infestations | Hydroxyurea | 7 | 104 | 8 |
| other | Other infections | Infections and infestations | Placebo | 14 | 103 | 14 |
| other | Others (e.g., injury) | Injury, poisoning and procedural complications | Hydroxyurea | 7 | 104 | 7 |
| other | Others (e.g., injury) | Injury, poisoning and procedural complications | Placebo | 9 | 103 | 10 |
| other | Anemia | Blood and lymphatic system disorders | Hydroxyurea | 25 | 104 | 40 |
| other | Anemia | Blood and lymphatic system disorders | Placebo | 42 | 103 | 65 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Hydroxyurea | 11 | 104 | 12 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Placebo | 4 | 103 | 4 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01976416/events